MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome

BACKGROUND: A subset of patients with neuromyelitis optica spectrum disorders (NMOSD) has been shown to be seropositive for myelin oligodendrocyte glycoprotein antibodies (MOG-IgG). OBJECTIVE: To describe the epidemiological, clinical, radiological, cerebrospinal fluid (CSF), and electrophysiologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Jarius, Sven, Ruprecht, Klemens, Kleiter, Ingo, Borisow, Nadja, Asgari, Nasrin, Pitarokoili, Kalliopi, Pache, Florence, Stich, Oliver, Beume, Lena-Alexandra, Hümmert, Martin W., Ringelstein, Marius, Trebst, Corinna, Winkelmann, Alexander, Schwarz, Alexander, Buttmann, Mathias, Zimmermann, Hanna, Kuchling, Joseph, Franciotta, Diego, Capobianco, Marco, Siebert, Eberhard, Lukas, Carsten, Korporal-Kuhnke, Mirjam, Haas, Jürgen, Fechner, Kai, Brandt, Alexander U., Schanda, Kathrin, Aktas, Orhan, Paul, Friedemann, Reindl, Markus, Wildemann, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086042/
https://www.ncbi.nlm.nih.gov/pubmed/27793206
http://dx.doi.org/10.1186/s12974-016-0718-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5086042/
https://www.ncbi.nlm.nih.gov/pubmed/27793206
http://dx.doi.org/10.1186/s12974-016-0718-0

Ejemplares similares